CBARA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.490200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.507800E-01
Normal-vs-Stage2
2.300000E-01
Normal-vs-Stage3
4.728000E-01
Normal-vs-Stage4
2.545200E-01
Stage1-vs-Stage2
3.696200E-01
Stage1-vs-Stage3
6.682600E-01
Stage1-vs-Stage4
3.864600E-01
Stage2-vs-Stage3
9.728200E-01
Stage2-vs-Stage4
5.218400E-01
Stage3-vs-Stage4
7.356800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.054200E-01
Normal-vs-AfricanAmerican
1.183170E-01
Normal-vs-Asian
5.222400E-02
Caucasian-vs-AfricanAmerican
2.256200E-01
Caucasian-vs-Asian
7.301500E-02
AfricanAmerican-vs-Asian
9.117200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.638600E-01
Normal-vs-Female
2.455400E-01
Male-vs-Female
6.643200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.502400E-01
Normal-vs-Age(41-60Yrs)
7.455800E-02
Normal-vs-Age(61-80Yrs)
3.856000E-01
Normal-vs-Age(81-100Yrs)
1.174750E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.657980E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.669000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.684400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.005800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.656000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.458800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.652200E-01
Normal-vs-Daily Drinker
2.897000E-01
Normal-vs-Weekly Drinker
7.740100E-02
Normal-vs-Occasional Drinker
1.148410E-01
Normal-vs-Social Drinker
2.561200E-01
Non Drinker-vs-Daily Drinker
4.572000E-01
Non Drinker-vs-Weekly Drinker
2.261800E-01
Non Drinker-vs-Occasional Drinker
3.905000E-01
Non Drinker-vs-Social Drinker
7.784600E-01
Daily Drinker-vs-Weekly Drinker
6.235800E-01
Daily Drinker-vs-Occasional Drinker
9.463600E-01
Daily Drinker-vs-Social Drinker
6.718000E-01
Weekly Drinker-vs-Occasional Drinker
5.859600E-01
Weekly Drinker-vs-Social Drinker
2.964400E-01
Occasional Drinker-vs-Social Drinker
5.470400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.249840E-01
Normal-vs-Grade 2
8.362700E-03
Normal-vs-Grade 3
5.130100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.658000E-03
Grade 1-vs-Grade 3
1.253960E-01
Grade 1-vs-Grade 4
1.249840E-01
Grade 2-vs-Grade 3
1.961230E-01
Grade 2-vs-Grade 4
8.362700E-03
Grade 3-vs-Grade 4
5.130100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.979600E-01
Normal-vs-NonDiabetic
2.124200E-01
Diabetic-vs-NonDiabetic
3.723000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.842400E-02
Normal-vs-NoPancreatitis
2.935600E-01
Pancreatitis-vs-NoPancreatitis
1.820560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.902990E-01
Normal-vs-N1
2.665200E-01
N0-vs-N1
6.930600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.839360E-01
Normal-vs-TP53-NonMutant
5.048000E-01
TP53-Mutant-vs-TP53-NonMutant
3.832200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
